CIK 0001764013
- Large accelerated filer
Immunovant, Inc.
Sign in to watch- Ticker
- IMVT
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Mar 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 832771572
- Phone
- +1 917-410-3120
- Business address
- 1000 PARK FORTY PLAZA, DURHAM, NC, 27713
- Former names
- Health Sciences Acquisitions Corp
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $895,852
- in 9 filings, $173K under 10b5-1 plans
Net −$895,852. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-04-02 | MIGAUSKY GEORGE V Director | Grant or award | +11,255 | 121,063 | ||
| 2024-04-02 | MIGAUSKY GEORGE V Director | Grant or award · Stock Option (right to buy) | +4,690 | 4,690 | ||
| 2024-04-02 | Pande Atul Director | Grant or award | +11,255 | 94,413 | ||
| 2024-04-02 | Pande Atul Director | Grant or award · Stock Option (right to buy) | +4,690 | 4,690 | ||
| 2024-04-02 | Torti Frank Director | Grant or award | +120,400 | 635,674 | ||
| 2024-04-02 | Torti Frank Director | Grant or award · Stock Option (right to buy) | +50,167 | 50,167 | ||
| 2024-04-02 | Stout Jay S Chief Technology Officer | Grant or award | +54,978 | 154,978 | ||
| 2024-04-02 | Stout Jay S Chief Technology Officer | Grant or award · Stock Option (right to buy) | +68,723 | 68,723 | ||
| 2024-04-02 | Levine Mark S. Chief Legal Officer | Grant or award | +54,978 | 356,946 | ||
| 2024-04-02 | Levine Mark S. Chief Legal Officer | Grant or award · Stock Option (right to buy) | +68,723 | 68,723 | ||
| 2024-04-02 | Macias William L. Chief Medical Officer | Grant or award | +54,978 | 385,930 | ||
| 2024-04-02 | Macias William L. Chief Medical Officer | Grant or award · Stock Option (right to buy) | +68,723 | 68,723 | ||
| 2024-04-02 | Geffner Michael Chief Medical Officer | Grant or award | +54,978 | 144,877 | ||
| 2024-04-02 | Geffner Michael Chief Medical Officer | Grant or award · Stock Option (right to buy) | +68,723 | 68,723 | ||
| 2024-04-02 | Butchko Julia G. Chief Development Officer | Grant or award | +54,978 | 462,795 | ||
| 2024-04-02 | Butchko Julia G. Chief Development Officer | Grant or award · Stock Option (right to buy) | +68,723 | 68,723 | ||
| 2024-04-02 | Barnett Eva Renee Chief Financial Officer | Grant or award | +54,978 | 375,398 | ||
| 2024-04-02 | Barnett Eva Renee Chief Financial Officer | Grant or award · Stock Option (right to buy) | +68,723 | 68,723 | ||
| 2024-04-02 | Salzmann Peter Chief Executive Officer | Grant or award | +160,534 | 1,091,765 | ||
| 2024-04-02 | Salzmann Peter Chief Executive Officer | Grant or award · Stock Option (right to buy) | +200,667 | 200,667 |
Page 14 of 18 · 351 trades